Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma
Patrick Chun(University of Michigan), Mukesh K. Nyati(University of Michigan)
Cited by 78
Related Papers
Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475.
|Journal of Clinical Oncology|2014|40
Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL).
|Journal of Clinical Oncology|2014|25
ATM is the primary kinase responsible for phosphorylation of Hsp90α after ionizing radiation
|Oncotarget|2016|23
Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
|Journal for ImmunoTherapy of Cancer|2014|12